Archives
-
o2h Ventures backed Arecor Granted Key US Patent
14 May, 2021
-
o2h Ventures backed Small Pharma Raises Cash to Fund Reverse Takeover on Toronto Stock Exchange
12 May, 2021
-
o2h Ventures backed In4Derm Announces a Strategic Partnership with a Nasdaq listed biotech with a >$200m Option License Agreement
11 May, 2021
-
Sunil Shah, CEO of o2h ventures, wins the Cambridge Independent Science and Technology Awards as CEO of the Year
16 April, 2021
-
University of Sussex and o2h Ventures Announce Creation and Investment in Stingray Bio, a Company for New Oncology Drugs Targeting the LMTK3 Kinase Pathway
08 April, 2021
-
The o2h human health S/EIS flagship fund – Fully Deployed
01 April, 2021
-
o2h Ventures invests into SomaServe’s successful Series A funding round
31 March, 2021
-
o2h Ventures invests in PhoreMost Series B financing
23 March, 2021
-
o2h Human Health EIS Fund leads an investment into Kuano, using quantum and AI to accelerate the development of new medicine.
25 February, 2021
invest in the growth potential of UK life science & AI